Evidence map›Paper›PMID 38074464›Full record

ArticleComputational and structural biotechnology journal2023

An integrated computational biology approach defines the crucial role of TRIP13 in pancreatic cancer.

Swati Dhasmana, Anupam Dhasmana, Stella Rios, Iris A Enriquez-Perez, Sheema Khan, Farrukh Afaq, Shafiul Haque, Upender Manne, Murali M Yallapu, Subhash C Chauhan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. MUC13-Associated Molecular Interactome in Pancreatic Cancer.Computational and structural biotechnology journal · 2026
    Article
  2. Article
  3. Role of TRIP13 in human cancer development.Molecular biology reports · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

Swati DhasmanaDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, USA.
Anupam DhasmanaDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, USA.
Stella RiosDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, USA.
Iris A Enriquez-PerezDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, USA.
Sheema KhanDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, USA.
Farrukh AfaqDepartment of Pathology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
Shafiul HaqueResearch and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan, Saudi Arabia.
Upender ManneDepartment of Pathology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
Murali M YallapuDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, USA.
Subhash C ChauhanDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, USA.
The University of Texas Rio Grande Valley · USUniversity of Alabama at Birmingham · USAjman University · AE

Funding

Bridges to the Baccalaureate Research Training Program at The University of Texas Rio Grande ValleyT34GM137854 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI CHEW, SUE ANNE, GALVEZ, GRISELDA LOPEZ · 2020 to 2024
$1.9M
MUC13 Mucin in Colorectal Cancer Health DisparityR01CA204552 · NCI · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI CHAUHAN, SUBHASH C. · 2016 to 2020
$1.7M
Development of Targeted Nanotechnology Platform for Pancreatic CancerR01CA206069 · NCI · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI CHAUHAN, SUBHASH C. · 2016 to 2021
$1.7M
Targeted Nanotherapy for Pancreatic CancerR01CA210192 · NCI · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI CHAUHAN, SUBHASH C. · 2016 to 2021
$1.7M
miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancerSC1GM139727 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI YALLAPU, MURALI MOHAN · 2021 to 2024
$1.5M
NCI NIH HHS R01 CA204552NCI NIH HHS R01 CA206069NCI NIH HHS R01 CA210192NIGMS NIH HHS SC1 GM139727NIGMS NIH HHS T34 GM137854
6 · The paper itself

Abstract

Pancreatic cancer (PanCa) is one of the most aggressive forms of cancer and its incidence rate is continuously increasing every year. It is expected that by 2030, PanCa will become the 2

Indexed as

Computational biologyEarly events of cancerIntegrative BiologyPancreatic cancerTranscriptomicsTRIP13

Identifiers

PMID38074464
PMCPMC10709078
OpenAlexW4388766103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.